ArticleJournal of experimental & clinical cancer research : CR2017

Combined targeting of Arf1 and Ras potentiates anticancer activity for prostate cancer therapeutics.

Liwei Lang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.